UVA Pharmacology’s Dr. Stevan Djuric has published an article in Movement Disorders titled “Addressing the Challenges of Translating LRRK2 Biology into Disease-Modifying Therapies: The LRRK2 Investigative Therapeutics Exchange Initiative.”

Dr. Djuric has been working with the Michael J Fox Foundation to look for regulators of the LRRK2 protein in Parkinson’s Disease.

Congratulations Dr. Djuric!